【《美国医学协会杂志》1987年4月】一种商品名称为 Hyate:C 的猪抗血友病因子Ⅷ:C 已得到美国食品药品管理局的批准,可用于治疗某些血友病的病人,例如正在发生对生命有威胁的或影响肢体会残废的出血的病人,或者需要进行手术的病人。这种制剂仅适用于下列的血友病病人:有抗人因子Ⅷ:C 抗体的病人,其它治疗方法均已用过或可能无效的病人。在人血的凝血反应过程中,可用猪因子ⅧC 来 ["Journal of the American Medical Association, April 1987] A pig anti-haemophilia factor VIII: C with the Hyate: C designation has been approved by the U.S. Food and Drug Administration for the treatment of certain hemophilia patients Such as patients undergoing life-threatening or bleeding disability affecting limbs, or patients undergoing surgery. This preparation applies only to the following hemophiliacs: patients with anti-human factor Ⅷ: C antibodies, and patients whose other treatments have been or may not be effective. In the process of coagulation of human blood, pig factor VIII C can be used